Substrate induced structural and dynamics changes in human phosphomevalonate kinase and implications for mechanism.
Phosphomevalonate kinase (PMK) catalyzes an essential step in the mevalonate pathway, which is the only pathway for synthesis of isoprenoids and steroids in humans. PMK catalyzes transfer of the gamma-phosphate of ATP to mevalonate 5-phosphate (M5P) to form mevalonate 5-diphosphate. Bringing these phosphate groups in proximity to react is especially challenging, given the high negative charge density on the four phosphate groups in the active site. As such, conformational and dynamics changes needed to form the Michaelis complex are of mechanistic interest. Herein, we report the characterization of substrate induced changes (Mg-ADP, M5P, and the ternary complex) in PMK using NMR-based dynamics and chemical shift perturbation measurements. Mg-ADP and M5P K(d)'s were 6-60 microM in all complexes, consistent with there being little binding synergy. Binding of M5P causes the PMK structure to compress (tau(c) = 13.5 nsec), whereas subsequent binding of Mg-ADP opens the structure up (tau(c) = 15.6 nsec). The overall complex seems to stay very rigid on the psec-nsec timescale with an average NMR order parameter of S(2) approximately 0.88. Data are consistent with addition of M5P causing movement around a hinge region to permit domain closure, which would bring the M5P domain close to ATP to permit catalysis. Dynamics data identify potential hinge residues as H55 and R93, based on their low order parameters and their location in extended regions that connect the M5P and ATP domains in the PMK homology model. Likewise, D163 may be a hinge residue for the lid region that is homologous to the adenylate kinase lid, covering the "Walker-A" catalytic loop. Binding of ATP or ADP appears to cause similar conformational changes; however, these observations do not indicate an obvious role for gamma-phosphate binding interactions. Indeed, the role of gamma-phosphate interactions may be more subtle than suggested by ATP/ADP comparisons, because the conservative O to NH substitution in the beta-gamma bridge of ATP causes a dramatic decrease in affinity and induces few chemical shift perturbations. In terms of positioning of catalytic residues, binding of M5P induces a rigidification of Gly21 (adjacent to the catalytically important Lys22), although exchange broadening in the ternary complex suggests some motion on a slower timescale does still occur. Finally, the first nine residues of the N-terminus are highly disordered, suggesting that they may be part of a cleavable signal or regulatory peptide sequence.
Olson
Andrew L
AL
Chemical Proteomics Facility at Marquette, Department of Chemistry, Marquette University, Milwaukee, Wisconsin 53201-1881, USA.
Yao
Huili
H
Herdendorf
Timothy J
TJ
Miziorko
Henry M
HM
Hannongbua
Supa
S
Saparpakorn
Patchareenart
P
Cai
Sheng
S
Sem
Daniel S
DS
D000255:Adenosine Triphosphate / Q000378:metabolism; D006801:Humans; D008798:Mevalonic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D008958:Models, Molecular; D019906:Nuclear Magnetic Resonance, Biomolecular; D017856:Phosphotransferases (Phosphate Group Acceptor) / Q000737:chemistry* / Q000378:metabolism*; D011485:Protein Binding; D011487:Protein Conformation; D013379:Substrate Specificity
C045038:phosphomevalonic acid; D000255:Adenosine Triphosphate; D017856:Phosphotransferases (Phosphate Group Acceptor); C022371:phosphomevalonate kinase; D008798:Mevalonic Acid
J Biomol NMR. 1994 Sep;4(5):603-14
22911360
J Mol Biol. 1995 Feb 10;246(1):144-63
7531772
Protein Eng Des Sel. 2004 Jan;17(1):107-12
14985543
J Biol Chem. 1959 Oct;234:2595-604
13801508
J Mol Biol. 2003 Oct 31;333(4):781-815
14568537
Biochemistry. 1994 Jun 7;33(22):6739-49
8204609
J Mol Biol. 1998 May 8;278(3):667-86
9600847
Nature. 2007 Dec 6;450(7171):913-6
18026087
J Biol Chem. 2003 Feb 14;278(7):4510-5
12424232
J Biol Chem. 2008 Jan 25;283(4):2042-8
17998210
J Magn Reson. 2000 Apr;143(2):423-6
10729271
Eur J Biochem. 1999 Sep;264(3):765-74
10491122
Proteins. 2004 Nov 15;57(3):468-80
15382240
Biochemistry. 2007 Oct 23;46(42):11780-8
17902708
Arch Biochem Biophys. 2006 Oct 15;454(2):189-96
16973124
Biochemistry. 2006 Sep 26;45(38):11414-24
16981701
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18055-60
17989222
Biochemistry. 1980 May 27;19(11):2300-4
6248100
Structure. 1996 Feb 15;4(2):147-56
8805521
Biochemistry. 1994 May 17;33(19):5984-6003
7514039
J Biomol NMR. 1996 Oct;8(3):273-84
8953218
EMBO J. 1996 Jul 15;15(14):3487-97
8670851
Biochemistry. 2002 May 21;41(20):6271-81
12009888
Biochemistry. 1989 Nov 14;28(23):8972-9
2690953
J Biol Chem. 2008 Jun 27;283(26):18292-302
18434310
Biochemistry. 2006 Mar 14;45(10):3235-42
16519518
J Mol Biol. 1993 Feb 20;229(4):1165-74
8445645
Adv Enzymol Relat Areas Mol Biol. 1999;73:103-34, x
10218107
Protein Sci. 2005 May;14(5):1134-9
15802646